Member Info for doze

Not taking off yet http://www.proactiveinvestors.co.uk/companies/news/116092/tissue-regenix-ahead-of-schedule-with-us-roll-out-116092.html

http://www.amazon.co.uk/s/ref=nb_sb_ss_i_1_8/279-3389077-2081604?url=search-alias%3Daps&field-keywords=vamousse+head+lice+treatment&sprefix=vamousse%2Caps%2C467 http://www.amazon.co.uk/s/ref=nb_sb_ss_c_0_9?url=search-alias%3Daps&field-keywords=head+lice+treatment&sprefix=head+lice%2Caps%2C231&rh=i%3Aaps%2Ck%3Ahead+lice+treatment It crops up on an amazon search- quite a pricey product

I suppose some will want to take this and others would prefer to sell before it goes ex div so big sells when the details are out and the sp has maxed might give a last minute buying opportunity depending if the business is on course.

When do you think the big dividend will be announced? Are you a laid off worker?

I expect there has been more to finalise and maybe payment details for dividend to wait for. Fingers crossed for next week.

potentially crippling debt mountain now the latest loan cost 15% and option on 15% of the company which would lift Henderson equity to 28% http://www.lse.co.uk/share-regulatory-news.asp?shareprice=ESG&ArticleCode=4zx63hck&ArticleHeadline=Loan_from_Substantial_Shareholder

announcement of the Company's preliminary results for the year ended 30 June 2015, which are expected to be released during the week commencing 5 October 2015. one day this week though

I should ask Scott what he is up to.

I would say so, oh, and dilute us massively. Needs must.

The bod should not delay payment announcement if they already know the details which they should by now. It makes you think things are not going well if they drag it out. Results should be an absolute deadline or a really good excuse given.

http://ir.xeneticbio.com/secfiling.cfm?filingid=1647488-15-123&CIK=1534525 Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On September 30, 2015, Xenetic Bioscience, Inc. (the “Company”) filed with the Secretary of State of the State of Nevada an Amendment to Articles of Incorporation to increase the authorized shares of Common Stock of the Company (the “Amendment”). The Amendment authorizes the Company to issue 1,500,000,000 shares of Common Stock, par value $0.001 per share, and 10,000,000 shares of Preferred Stock. The Preferred Stock may be issued in one or more series, each series to be appropriately designated by a distinguishing letter or title, prior to the issuance of any shares thereof. The Amendment was recommended by the board of directors and submitted for consideration and approval to the Company’s shareholders at an annual meeting held on September 24, 2015. The Amendment was approved by shareholders holding a majority of the issued and outstanding common stock.

http://www.lse.co.uk/share-regulatory-news.asp?shareprice=ESG&ArticleCode=pxi8cvoq&ArticleHeadline=HomeSend_Capital_Raise_and_Core_Business_Update The delay in signing key opportunities will have consequent effect on cash collection, and therefore the Company expects to have limited working capital from operations over the next few months. In addition, the Board currently intends to participate in the capital raising in HomeSend referred to above. For these two reasons, the Board is looking to raise approximately £2.5M shortly and up to a total of £5M before April 2016. The Company is currently in discussions with a shareholder regarding a possible loan of up to £5M. The Company will make a further announcement in due course to update the market on the outcome of these discussions. As previously stated at the Annual General Meeting on 24 March 2015, the Board is mindful that eServGlobal is a company of two parts - an established core business and a start-up with high growth potential. The Board continues to keep under continuous review the best ways in which to manage the Company to enhance shareholder value. It's hard work for the board but they need commending for their communication.

Have you got news of lpg prices- shell's main business?

More on Scott's financial side: http://www.healthcp.com/management link to last post: http://www.xeneticbio.com/Copy%20%20of%20m-scott-maguire

Investment banker then, similar training- M Scott Maguire, MBA Chief Executive Officer Mr. Maguire joined Xenetic as Chief Executive Officer in April 2004. His background is in life sciences and healthcare investment banking and he has advised many US and European companies on capital raisings and commercial development over his 22 year career. Mr. Maguire began his banking career with Merrill Lynch in 1987 in New York and, after receiving his MBA in 1993, joined the healthcare division of W.R. Grace National Medical Care, where he helped create the international healthcare division. In 1996, he co-founded the Arthur Andersen global healthcare corporate finance practice based in London. Mr. Maguire is currently director of Healthcare Capital Partners Limited, a healthcare corporate finance and proprietary investment boutique he co-founded in 2002, and a non-executive director of Renal Services Ltd, a company focused on dialysis service provision in the UK.

I didn't think there were too many directors left so saving money, Scott is an accountant.

seems to be causing a drip in the SP

Price bought is nearer the bottom of the quoted spread on the exchange than the top and as the reporting is automatic as opposed to broker informed, you will not know if a buy or sell. I looking forward to seeing the income figures here.

http://ir.xeneticbio.com/secfiling.cfm?filingid=1019687-15-3344&CIK=1534525 On August 27, 2015, our CFO and director Colin Hill retired as a member of our board of directors and as Chief Financial Officer. http://www.xeneticbio.com/colin-william-hill due to being UK based?

You can sign up here, wait for the redirect wwwdottelecomplusdotorgdotuk/910114 replace dot in three places with a fullstop. Click on earn with us to see what it is all about. Persistence and belief required but a good company.